Psychology Today

You Don't Need Validation—You Need This Instead

“I just need you to validate my feelings.” It's a phrase therapists, partners, and friends hear constantly—and it reveals something fascinating about our cultural moment. Validation has become the ...
FierceBiotech

Encoded deciphers path to pivotal trial with phase 1/2 Dravet gene therapy data

Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 to a 78% reduction in seizures, keeping the biotech on track to start a pivotal study next year. The Californian company’s ...
Business Wire

Encoded Therapeutics Presents Positive Interim Efficacy Data from Initial Dose Levels of Phase 1/2 Trials Evaluating ETX101 Gene Therapy in Dravet Syndrome

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe neurological disorders, today announced positive ...
STAT

Capricor says its cell therapy improved heart and muscle function in Duchenne patients

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
https//beincrypto.com

Dune Launches the dbt Connector and Positions the Platform as a Complete Crypto Data Warehouse

The new dbt Connector enables organizations to run fully managed data transformation pipelines directly on Dune, creating a unified environment for blockchain data engineering and analytics. [Buenos ...
Medscape

For Moderate-to-Severe Psoriasis, Novel Oral Therapy Acts Like a Biologic in Phase 3 Trial

Icotrokinra, a novel oral interleukin (IL)-23 inhibitor, provided a level of response in moderate-to-severe plaque psoriasis that is similar to that previously reported with injectable biologics, ...
urologytimes

Martin M. Miner, MD, outlines data on testosterone therapy

Martin M. Miner, MD, highlights key findings from TRAVERSE and the T4DM study. Miner is the co-director of the men’s health center at Brown University Health in Providence, Rhode Island. Miner began ...
Reuters

UniQure shares plummet as FDA says inadequate clinical data for Huntington's therapy

Nov 3 (Reuters) - UniQure (UQ1.F), opens new tab said the U.S. Food and Drug Administration no longer agreed that clinical data for the Dutch company's gene therapy for Huntington's disease may be ...
GEN

uniQure Staggers as FDA Questions Data for Huntington’s Gene Therapy Candidate

uniQure has acknowledged that what it called “game changing” data in September showing significant slowing of Huntington’s disease (HD) progression in patients treated with its gene therapy candidate ...